Massimo Pini

Coordinating Center Of The Network For Rare Diseases Of Piedmont And Aosta Valley
Turin, 10154, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Short BRAF+MEK coinhibition, alone and combined with anti-CD20 immunotherapy, in relapsed or refractory hairy cell leukemia: An investigator-sponsored multi-center phase 2 clinical trial.

Short BRAF+MEK coinhibition, alone and combined with anti-CD20 immunotherapy, in relapsed or refractory hairy cell leukemia: An investigator-sponsored multi-center phase 2 clinical trial.

Journal: HemaSphere

Published: April 30, 2026

Characterization of diarylethene-based photoswitches with core and valence photoabsorption and photoemission spectroscopies.

Characterization of diarylethene-based photoswitches with core and valence photoabsorption and photoemission spectroscopies.

Journal: The Journal of chemical physics

Published: January 15, 2026

Direct temporal characterization of sub-3-fs deep UV pulses generated by resonant dispersive wave emission: erratum.

Direct temporal characterization of sub-3-fs deep UV pulses generated by resonant dispersive wave emission: erratum.

Journal: Optics express

Published: June 14, 2025

Direct temporal characterization of sub-3-fs deep UV pulses generated by resonant dispersive wave emission.

Direct temporal characterization of sub-3-fs deep UV pulses generated by resonant dispersive wave emission.

Journal: Optics express

Published: September 15, 2023

Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies.

Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies.

Journal: The Lancet. Rheumatology

Published: October 26, 2021

Monoclonal Gammopathy of Renal Significance: Clinical and Histological Efficacy of a Bortezomib-Based Regimen.

Monoclonal Gammopathy of Renal Significance: Clinical and Histological Efficacy of a Bortezomib-Based Regimen.

Journal: Frontiers in medicine

Published: July 25, 2020

Antiemetic prophylaxis in patients undergoing hematopoietic stem cell transplantation: a multicenter survey of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) transplant programs.

Antiemetic prophylaxis in patients undergoing hematopoietic stem cell transplantation: a multicenter survey of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) transplant programs.

Journal: Annals of hematology

Published: November 08, 2018

Impact of New Drugs on the Long-Term Follow-Up of Upfront Tandem Autograft-Allograft in Multiple Myeloma.

Impact of New Drugs on the Long-Term Follow-Up of Upfront Tandem Autograft-Allograft in Multiple Myeloma.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Published: August 10, 2017

Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) score.

Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) score.

Journal: Bone marrow transplantation

Published: July 05, 2017

Long-term follow-up of allogeneic stem cell transplantation in relapsed/refractory Hodgkin lymphoma.

Long-term follow-up of allogeneic stem cell transplantation in relapsed/refractory Hodgkin lymphoma.

Journal: Bone marrow transplantation

Published: June 06, 2017

Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial).

Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 03, 2017

'Real-life' report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO).

'Real-life' report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO).

Journal: Bone marrow transplantation

Published: April 18, 2017

Showing 1-12 of 22

Last Updated: 09/26/2026